Preview

Experimental and Clinical Gastroenterology

Advanced search

Ganzya Application of probiotics in treatment of digestive tract dysbacteriosis

https://doi.org/10.31146/1682-8658-ecg-200-4-94-100

Abstract

This work analyzes the sensitivity of the resident and facultative microbiota of the oral cavity, stomach and duodenum of patients with infl ammatory and erosive — ulcerative diseases of the gastrointestinal tract to probiotic drugs with active ingredients: Bacilus subtilis 534, Lactobacillus acidophilus, Bifi dobacterium bifi dum and Bifi dobacterium longum. The studied microbiota showed a diff erent degree of sensitivity to the Lactobacillus acidophilus, and Bacilus subtilis 534, as well as absolute resistance to Bifi dobacterium bifi dum и Bifi dobacterium longum. Clinicians need to take into account that not all probiotic preparations can be eff ectively used in the treatment of dysbiosis of the digestive tract.

About the Authors

Yu. V. Chervinets
Tver State Medical University
Russian Federation

Yuliya V. Chervinets, MD, PhD of Department of Microbiology and Virology with the Course of Immunology

4, Sovetskaya St., Tver, 170100



V. M. Chervinets
Tver State Medical University
Russian Federation

Vyacheslav M. Chervinets, MD, PhD, Head of Department of Microbiology and Virology with the Course of Immunology

4, Sovetskaya St., Tver, 170100



D. V. Ganzya
Tver State Medical University
Russian Federation

Ganzya Denis Viktorovich, assistant at the Department of Neurology, Rehabilitation and Neurosurgery

4, Sovetskaya St., Tver, 170100



References

1. Global practice guidelines of the World Gastro enterological Organization. Probiotics and Prebiotics. 2017. (in Russ.)

2. Bondarenko V. M. Molecular cell mechanisms of the therapeutic action of probiotic drugs. Pharmateca. 2010; 2 (196): 26–32. (in Russ)

3. Shenderov B. A. Probiotics, prebiotics and synbiotics. General and selected sections of the problem. Food ingredients. Raw materials and additives. 2005; 2: 23–26. (in Russ.)

4. Shenderov B. A. Human microbial ecology and its role in maintaining health. Metamorphoses. 2014; 5: 72–80. (in Russ.)

5. Althaus M., Behnsen J., Deriu E., et al. Probiotics: properties, examples, and specifi c applications. Cold Spring Perspect Med. 2013;3: a0110074.

6. Shenderov B. A. Th e state and prospects of the concept of “Functional nutrition” in Russia: general and selected sections of the problem. Pharmateca. 2006; 1: 41–47. (in Russ.)

7. Shenderov B. A. Th e microfl ora of the digestive tract is the most important factor in the host’s microelement homeostasis. Clinical nutrition. 2005;(2): 2–5. (in Russ.)

8. Shenderov B. A. Functional nutrition as the most important factor in reducing the risk of obesity in children and adults. International Conference “Technologies and Healthy Food Products”. 2005; 292–297. (in Russ.)

9. Probiotics. Growth promoting factors produced by microorganisms. Science.1965;(147): 747–748.

10. Probiotics. West Point, CT: Avi Publishing Co. 1971.

11. Probiotics, the other half of the antibiotic story. Anim Nutr Health. 1974; 29:4–8.

12. Probiotics in man and animals. Appl Bacteriol. 1989; 66: 365–378.

13. FAO/OMS, Joint Food and Agriculture Organization of the United Nations. World Health Organization. Working Group. Report on draft ing guidelines for the evaluation of probiotics in food. 2002.

14. Hill C., Guarner F., Reid G., et al. Expert consensus document. Th e International Scientifi c Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506–514.

15. Floch M., Ringel Y., Walker W. A. Th e Microbiota in Gastrointestinal Pathophysiology. Implications for Human Health, Prebiotics, Probiotics, and Dysbiosis. 2017; 227.

16. Tiffany C. R., Baumler A. J. Dysbiosis: from fiction to function. Am J Physiol Gastrointest Liver Physiol. 2019;317(5): G602-G608.

17. Kuznetsova E. N., Ploskireva A. A., Merzlyakov M. Yu., et al. Results of a study of the effi cacy and safety of probiotics during regular exercise in healthy volunteers. Bulletin of new medical technologies. 2016;(4): 178–182. (in Russ.)

18. Zyryanov S.K., Galeeva Zh.A., Belousov Yu. B. Probiotics, prebiotics, and antibiotic- associated diarrhea: truth and myth. Practical Pulmonology. 2015;(2): 38–40 (in Russ.)

19. Serkova M. Yu., Avalueva E. B., Pavlova E. Yu., Orlov S. V. Correction of digestive disorders with probiotics in patients receiving chemotherapy with lung cancer. Experimental and clinical gastroenterology. 2017; 2 (138): 71–76. (in Russ.)

20. Ciorba M.A. A Gastroenterologist’s Guide to Probiotics. A concise and practical review on the use of probiotics for gastrointestinal disease and symptoms. Clin Gastroenterol Hepatol. 2012;(10):960–968.

21. Stockenhuber A., Kamhuber C., Leeb G., et al. Preventing antibiotic associated diarrhoea using a probiotic Lactobacillus casei preparation. Gut. 2008; 57(suppl II):20.

22. Liu Z.H., Huang M. J., Zhang X. W., et al. Th e eff ects of perioperative probiotic treatment on serum zonulin concentration and subsequent postoperative infectious complications aft er colorectal cancer surgery: a doublecenter and double- blind randomized clinical trial. Am J Clin Nutr.2012

23. Hemalatha R., Ouwehand A. C., Forssten S. D., et al. A Community-based Randomized Double Blind Controlled Trial of Lactobacillus paracasei and Bifi dobacterium lactis on Reducing Risk for Diarrhea and Fever in Preschool Children in an Urban Slum in India. Eur J Nutr Food Safety. 2014.

24. Chitapanarux I., Chitapanarux T., Traisathit P., et al. Randomized controlled trial of live lactobacillus acidophilus plus bifi dobacteriumbifi dum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiat Oncol. 2010; 5:31.

25. Blinkova L. P. Bacteriocins: criteria, classifi cation, detection methods. Journal. Microbiol. 2003;(3): 109–113. (in Russ.)


Review

For citations:


Chervinets Yu.V., Chervinets V.M., Ganzya D.V. Ganzya Application of probiotics in treatment of digestive tract dysbacteriosis. Experimental and Clinical Gastroenterology. 2022;(4):94-100. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-200-4-94-100

Views: 290


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1682-8658 (Print)